Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis

BACKGROUND: Type 2 diabetes and obesity, as states of chronic inflammation, are risk factors for severe COVID-19. Metformin has cytokine-reducing and sex-specific immunomodulatory effects. Our aim was to identify whether metformin reduced COVID-19-related mortality and whether sex-specific interacti...

Descripción completa

Detalles Bibliográficos
Autores principales: Bramante, Carolyn T, Ingraham, Nicholas E, Murray, Thomas A, Marmor, Schelomo, Hovertsen, Shane, Gronski, Jessica, McNeil, Chace, Feng, Ruoying, Guzman, Gabriel, Abdelwahab, Nermine, King, Samantha, Tamariz, Leonardo, Meehan, Thomas, Pendleton, Kathryn M, Benson, Bradley, Vojta, Deneen, Tignanelli, Christopher J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd. 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832552/
https://www.ncbi.nlm.nih.gov/pubmed/33521772
http://dx.doi.org/10.1016/S2666-7568(20)30033-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832552/
https://www.ncbi.nlm.nih.gov/pubmed/33521772
http://dx.doi.org/10.1016/S2666-7568(20)30033-7

Ejemplares similares